<DOC>
	<DOCNO>NCT01038440</DOCNO>
	<brief_summary>The purpose study assess relationship dose time consumption stearidonic acid ( SDA ) eicosapentaenoic acid ( EPA ) EPA enrichment red blood cell ( RBC ) membrane men woman .</brief_summary>
	<brief_title>Time Dose Evaluation Stearidonic Acid ( SDA ) Eicosapentaenoic Acid ( EPA ) Red Blood Cells</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Death</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<criteria>1 . Male female , 21 65 year age , inclusive . 2 . Body mass index ( BMI ) 18.0039.99 kg/m2 , visit 1 ( week 2 ) . 3 . Subject willing avoid alcohol consumption 24 hr prior every clinic visit . 4 . The subject plan change smoke habit study period . 5 . Subject willing maintain stable body weight , current activity level , dietary habit except use study product direct . 6 . Subject understands study procedure sign form document informed consent participate study authorization release relevant protect health information study Investigator . 1 . Subject coronary heart disease coronary heart disease risk equivalent include follow : Diabetes mellitus ( fast glucose ≥126 mg/dL visit 1 ) . Clinical sign atherosclerosis include peripheral arterial disease , abdominal aortic aneurysm , certain type carotid artery disease . Presence multiple risk factor give person great 20 % chance develop coronary artery disease within 10 year determine Framingham risk index calculate visit 1 . 2 . Triglycerides ≥400 mg/dL visit 1 ( week 2 ) . 3 . If smoker , subject smoke 1 pack cigarette ( 20 cigarette ) per day . 4 . Abnormal laboratory test result clinical importance , include , limited , fast creatinine ≥1.5 mg/dL , ALT AST ≥1.5X upper limit normal fast glucose ≥126 mg/dL visit 1 . 5 . Uncontrolled hypertension , define rest systolic blood pressure ≥160 mm Hg diastolic blood pressure ≥100 mm Hg screening . 6 . Use lipidaltering drug , include statin , bile acid sequestrants , cholesterol absorption inhibitor , fibrates , prescription formulation niacin within four week visit 1 throughout study . 7 . Use EPA/DHA drug supplement within four month visit 1 throughout study period . 8 . Frequent use nonstudyrelated EPA/DHA contain enrich food ( DHAenriched eggs ) within four month visit 1 throughout study period . 9 . Use flaxseed , perilla seed , hemp , spirulina , walnut , mustard seed black currant oil one week duration within four week visit 1 . 10 . Consumption fatty fish ( salmon , herring , mackerel , albacore tuna , sardine ) twice per month within four month visit 1 throughout study period . 11 . Use dietary supplement know alter lipid metabolism . 12 . Use weightloss medication ( prescription overthe counter ) within four week prior visit 1 throughout study . 13 . Use weight loss supplement program within four week visit 1 throughout study . 14 . Females pregnant , plan pregnant study period , lactate , woman childbearing potential unwilling commit use medically approve form contraception throughout study period . 15 . History presence significant , renal , hepatic , gastrointestinal , pulmonary , biliary , neurological endocrine disorder . 16 . History presence cancer , except nonmelanoma skin cancer . 17 . Current recent history ( within 12 month visit 1 , week 1 ) strong potential alcohol substance abuse . 18 . Use investigational drug within 30 day prior visit 1 . 19 . Individual condition Investigator believe would interfere ability provide inform consent , comply study protocol , might confound interpretation study result put person undue risk . 20 . Medications and/or supplement know influence lipid metabolism body weight allow within four week visit 1 . Unstable use antihypertensive thyroid medication also permit .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Omega 3 fatty acid</keyword>
	<keyword>Omega 3 Index</keyword>
	<keyword>Stearidonic acid ( SDA )</keyword>
	<keyword>Eicosapentaenoic acid ( EPA )</keyword>
	<keyword>Red blood cell</keyword>
	<keyword>Lipids</keyword>
	<keyword>Inflammation marker</keyword>
</DOC>